Pergolide Availability: No FDA Announcement, Supplies Running Low
More than a month after pergolide mesylate, a drug commonly used to treat pituitary pars intermedia dysfunction (PPID), also known as equine Cushing’s disease, was withdrawn for human use, the FDA has yet to make an announcement on whether
- Topics: Article, Cushing's Disease
Share
ADVERTISEMENT
Create a free account with TheHorse.com to view this content.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.
Start your free account today!
Already have an account?
and continue reading.
Share
Erin Ryder is a former news editor of The Horse: Your Guide To Equine Health Care.
Related Articles
Stay on top of the most recent Horse Health news with
